Skip to main content
Clinical Trials/NCT03697967
NCT03697967CompletedNot Applicable

Supine vs Prone Position During Delayed Cord Clamping in Term Infants A Randomized Trial

Maisonneuve-Rosemont Hospital1 site in 1 country210 target enrollmentStarted: March 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
210
Locations
1
Primary Endpoint
Hemoglobin and hematocrit

Study Overview

Brief Summary

This study is conducted to evaluate if the prone position of the newborn on the chest of his mother at birth before delayed cord clamping leads to better hematocrit and hemoglobin at 24-48 hours of life compared to supine position.

Detailed Description

At 30 hours of life, laboratory personnel drew a capillary sample from the infant's heel for hemoglobin, hematocrit, and total serum bilirubin at the same time as the newborn metabolic screening sample. There is no added heelstick to routine care, as current standard in our institution requires the bilirubin to be drawn at 30 hours of life.

During universal screening for congenital cardiac defects (30 hours of life), a value of cerebral saturation (CrSO2) is measured using NIRS with INVOS (In Vivo Optical Spectroscopy, INVOS System, Covidien, Dublin, Ireland, Somanetics). Sensors are placed over the forehead and the newborn is in supine position.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
1 Minute to 2 Minutes (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Newborn ≥ 36 weeks gestational age and Born vaginally and Well appearing

Exclusion Criteria

  • •Out born infant, Infant born by caesarian section, Preterm born less than 36 weeks GA, Infant with intra uterine growth restriction (IUGR: less than 10th percentile) Asphyxiated infant Infant needing immediate resuscitation, Newborn with malformation (gastroschisis, omphalocele, anal atresia, severe head skin injury, congenital cardiac disease Newborn with mother with preeclampsia or gestational hypertension or diabetes on insuline or hemolytic disease or on chemotherapy or on cortisone.

Arms & Interventions

Supine

Experimental

Infant placed supine for 120 seconds before cord clamping

Intervention: supine or prone position (Procedure)

Prone

Experimental

Infant placed prone for 120 seconds before cord clamping

Intervention: supine or prone position (Procedure)

Outcomes

Primary Outcomes

Hemoglobin and hematocrit

Time Frame: 24-48 hours

Hemoglobin value

Secondary Outcomes

  • Cerebral saturation by near infrared spectroscopy (NIRS)(24-48 H of life)
  • Bilirubin(24-48 hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr Brahim Bensouda

MD

Maisonneuve-Rosemont Hospital

Study Sites (1)

Loading locations...

Similar Trials